Track the 바스칸바이오제약 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 바스칸바이오제약 has logged 19 insider filings. Market capitalisation: €33.5bn. The latest transaction was reported on 30 March 2026 (Sale). Among the most active insiders: 민천기. Every trade is free.
19
Insider Decl.
0
Thresholds
·
10 ops.
Buy Volume
·
8 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 1,540 of 26,270 companies
78.0
score / 100
Value
86
Quality
70
FCF yld10%
Earn yld14%
EV/EBITDA6.5x
ROE·
Gross mgn27%
Net mgn14%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.